1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
• 1.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Inhalation Anesthetic Intermediates

1.2.3 Antiviral Drug Intermediates

1.2.4 Others

1.3 Market by Application

1.3.1 Global Fluorinated Pharmaceutical Intermediates Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Medicine Field

1.3.3 Health Field

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Fluorinated Pharmaceutical Intermediates Market Perspective (2017-2028)
• 2.2 Fluorinated Pharmaceutical Intermediates Growth Trends by Region
• 2.2.1 Fluorinated Pharmaceutical Intermediates Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Fluorinated Pharmaceutical Intermediates Historic Market Size by Region (2017-2022)

2.2.3 Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2023-2028)

2.3 Fluorinated Pharmaceutical Intermediates Market Dynamics

2.3.1 Fluorinated Pharmaceutical Intermediates Industry Trends

2.3.2 Fluorinated Pharmaceutical Intermediates Market Drivers

2.3.3 Fluorinated Pharmaceutical Intermediates Market Challenges

2.3.4 Fluorinated Pharmaceutical Intermediates Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue
• 3.1.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue (2017-2022)

3.1.2 Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Players (2017-2022)

3.2 Global Fluorinated Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Fluorinated Pharmaceutical Intermediates Revenue

3.4 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio

3.4.1 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Fluorinated Pharmaceutical Intermediates Revenue in 2021

3.5 Fluorinated Pharmaceutical Intermediates Key Players Head office and Area Served

3.6 Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service

3.7 Date of Enter into Fluorinated Pharmaceutical Intermediates Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Fluorinated Pharmaceutical Intermediates Breakdown Data by Type

• 4.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Type (2017-2022)
• 4.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2023-2028)

5 Fluorinated Pharmaceutical Intermediates Breakdown Data by Application

• 5.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Application (2017-2022)
• 5.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
• 6.2 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
• 6.3 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
• 6.4 United States
• 6.5 Canada

7 Europe

• 7.1 Europe Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
• 7.2 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
• 7.3 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
• 7.4 Germany
• 7.5 France
• 7.6 U.K.
• 7.7 Italy
• 7.8 Russia
• 7.9 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
• 8.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
• 8.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
• 8.4 China
• 8.5 Japan
• 8.6 South Korea
• 8.7 Southeast Asia
• 8.8 India
• 8.9 Australia

9 Latin America

• 9.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
• 9.2 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
• 9.3 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
• 9.4 Mexico
• 9.5 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size (2017-2028)
• 10.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2017-2022)
• 10.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2023-2028)
• 10.4 Turkey
• 10.5 Saudi Arabia
• 10.6 UAE

11 Key Players Profiles

• 11.1 Bayer
• 11.1.1 Bayer Company Detail

11.1.2 Bayer Business Overview

11.1.3 Bayer Fluorinated Pharmaceutical Intermediates Introduction

11.1.4 Bayer Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.1.5 Bayer Recent Development

11.2 DuPont

11.2.1 DuPont Company Detail

11.2.2 DuPont Business Overview

11.2.3 DuPont Fluorinated Pharmaceutical Intermediates Introduction

11.2.4 DuPont Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.2.5 DuPont Recent Development

11.3 BASF SE

11.3.1 BASF SE Company Detail

11.3.2 BASF SE Business Overview

11.3.3 BASF SE Fluorinated Pharmaceutical Intermediates Introduction

11.3.4 BASF SE Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.3.5 BASF SE Recent Development

11.4 Zhejiang Yongtai Technology

11.4.1 Zhejiang Yongtai Technology Company Detail

11.4.2 Zhejiang Yongtai Technology Business Overview

11.4.3 Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Introduction

11.4.4 Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.4.5 Zhejiang Yongtai Technology Recent Development

11.5 Jinzhou Hengtong Fluorine Chemicals

11.5.1 Jinzhou Hengtong Fluorine Chemicals Company Detail

11.5.2 Jinzhou Hengtong Fluorine Chemicals Business Overview

11.5.3 Jinzhou Hengtong Fluorine Chemicals Fluorinated Pharmaceutical Intermediates Introduction

11.5.4 Jinzhou Hengtong Fluorine Chemicals Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.5.5 Jinzhou Hengtong Fluorine Chemicals Recent Development

11.6 Fuxin Custchem Fine Chemical

11.6.1 Fuxin Custchem Fine Chemical Company Detail

11.6.2 Fuxin Custchem Fine Chemical Business Overview

11.6.3 Fuxin Custchem Fine Chemical Fluorinated Pharmaceutical Intermediates Introduction

11.6.4 Fuxin Custchem Fine Chemical Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.6.5 Fuxin Custchem Fine Chemical Recent Development

11.7 Shenzhen Capchem Technology

11.7.1 Shenzhen Capchem Technology Company Detail

11.7.2 Shenzhen Capchem Technology Business Overview

11.7.3 Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Introduction

11.7.4 Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.7.5 Shenzhen Capchem Technology Recent Development

11.8 NORINCO GROUP

11.8.1 NORINCO GROUP Company Detail

11.8.2 NORINCO GROUP Business Overview

11.8.3 NORINCO GROUP Fluorinated Pharmaceutical Intermediates Introduction

11.8.4 NORINCO GROUP Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.8.5 NORINCO GROUP Recent Development

11.9 Zhejiang Zhongxin Fluoride Materials

11.9.1 Zhejiang Zhongxin Fluoride Materials Company Detail

11.9.2 Zhejiang Zhongxin Fluoride Materials Business Overview

11.9.3 Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Introduction

11.9.4 Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.9.5 Zhejiang Zhongxin Fluoride Materials Recent Development

11.10 Jiangsu Feiyu Pharmaceutical Technology

11.10.1 Jiangsu Feiyu Pharmaceutical Technology Company Detail

11.10.2 Jiangsu Feiyu Pharmaceutical Technology Business Overview

11.10.3 Jiangsu Feiyu Pharmaceutical Technology Fluorinated Pharmaceutical Intermediates Introduction

11.10.4 Jiangsu Feiyu Pharmaceutical Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.10.5 Jiangsu Feiyu Pharmaceutical Technology Recent Development

11.11 JIANG LIN JIANG CHEMICAL

11.11.1 JIANG LIN JIANG CHEMICAL Company Detail

11.11.2 JIANG LIN JIANG CHEMICAL Business Overview

11.11.3 JIANG LIN JIANG CHEMICAL Fluorinated Pharmaceutical Intermediates Introduction

11.11.4 JIANG LIN JIANG CHEMICAL Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.11.5 JIANG LIN JIANG CHEMICAL Recent Development

11.12 Lianyungang Cca Chemical

11.12.1 Lianyungang Cca Chemical Company Detail

11.12.2 Lianyungang Cca Chemical Business Overview

11.12.3 Lianyungang Cca Chemical Fluorinated Pharmaceutical Intermediates Introduction

11.12.4 Lianyungang Cca Chemical Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.12.5 Lianyungang Cca Chemical Recent Development

11.13 Shaoxing Xingxin New Material

11.13.1 Shaoxing Xingxin New Material Company Detail

11.13.2 Shaoxing Xingxin New Material Business Overview

11.13.3 Shaoxing Xingxin New Material Fluorinated Pharmaceutical Intermediates Introduction

11.13.4 Shaoxing Xingxin New Material Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.13.5 Shaoxing Xingxin New Material Recent Development

11.14 Jiangsu Yongchuang Pharmaceutical Technology

11.14.1 Jiangsu Yongchuang Pharmaceutical Technology Company Detail

11.14.2 Jiangsu Yongchuang Pharmaceutical Technology Business Overview

11.14.3 Jiangsu Yongchuang Pharmaceutical Technology Fluorinated Pharmaceutical Intermediates Introduction

11.14.4 Jiangsu Yongchuang Pharmaceutical Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2017-2022)

11.14.5 Jiangsu Yongchuang Pharmaceutical Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
• 13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

Fluorine-containing intermediates are chemical raw materials or chemical products used in the process of drug synthesis. Such chemical products can be produced in ordinary chemical plants without a drug production license. Can be used for the synthesis of drugs.
Industry Insights

The global Fluorinated Pharmaceutical Intermediates market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Inhalation Anesthetic Intermediates accounting for % of the Fluorinated Pharmaceutical Intermediates global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Medicine Field segment is altered to an % CAGR throughout this forecast period.

China Fluorinated Pharmaceutical Intermediates market size is valued at US$ million in 2021, while the North America and Europe Fluorinated Pharmaceutical Intermediates are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fluorinated Pharmaceutical Intermediates landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fluorinated Pharmaceutical Intermediates market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fluorinated Pharmaceutical Intermediates market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fluorinated Pharmaceutical Intermediates market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fluorinated Pharmaceutical Intermediates market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Fluorinated Pharmaceutical Intermediates market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Fluorinated Pharmaceutical Intermediates Breakdown Data by Type

Inhalation Anesthetic Intermediates

Antiviral Drug Intermediates

Others

Fluorinated Pharmaceutical Intermediates Breakdown Data by Application

Medicine Field

Health Field

Regional Analysis

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Bayer

DuPont

BASF SE

Zhejiang Yongtai Technology

Jinzhou Hengtong Fluorine Chemicals

Fuxin Custchem Fine Chemical

Shenzhen Capchem Technology

NORINCO GROUP

Zhejiang Zhongxin Fluoride Materials

Jiangsu Feiyu Pharmaceutical Technology

JIANG LIN JIANG CHEMICAL

Lianyungang Cca Chemical

Shaoxing Xingxin New Material

Jiangsu Yongchuang Pharmaceutical Technology

Frequently Asked Questions

What factors will challenge the Fluorinated Pharmaceutical Intermediates market growth?

Which end-use segment will expand at the fastest CAGR in the Fluorinated Pharmaceutical Intermediates market?

Which are the emerging players in the Fluorinated Pharmaceutical Intermediates market?

How concentrated is the Fluorinated Pharmaceutical Intermediates market?

Which factors are positively contributing to the Fluorinated Pharmaceutical Intermediates market growth?

Which are the novel product innovations in the Fluorinated Pharmaceutical Intermediates market?

Which product segment will emerge as the most lucrative in the Fluorinated Pharmaceutical Intermediates market?

Which factors are increasing the competition in the Fluorinated Pharmaceutical Intermediates market?

Which are the strategic measures taken by the Fluorinated Pharmaceutical Intermediates industry players?

Which region will witness inactive growth during the forecast period?

What key trends are likely to emerge in the Fluorinated Pharmaceutical Intermediates market in the coming years?